This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Endoscopy/ Minimally Invasive Surgery  • Alert me on articles by topic

Michael R. Marohn, DO

Arch Surg. 2007;142(12):1205.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Sweet and colleagues provide a benchmark series of laparoscopic enucleation of pancreatic insulinomas. Insulinomas are the most common functional neuroendocrine pancreatic tumors; most are solitary and benign. Focusing on laparoscopic enucleation of these lesions is reasonable.

The authors report successful preoperative CT localization in only 5 of 9 patients, supplemented by EUS and successful in 2 of 3 patients with nondiagnostic CT scans. These data mirror other findings, with the caveat that EUS is heavily operator dependent and may reveal false-positive or false-negative results.¹ The authors' description of laparoscopic intraoperative ultrasonography (used in 6 of 9 patients) as being of principal value to confirm CT findings and to demonstrate the relationship of the lesion to pancreatic duct and vascular anatomy may underrate the usefulness of intraoperative ultrasonography. Given that preoperative noninvasive imaging localizes only 50% to 55% of lesions, laparoscopic intraoperative ultrasonography may be a key . . . [Full Text of this Article]

AUTHOR INFORMATION

RELATED ARTICLE

Laparoscopic Enucleation of Insulinomas
Matthew P. Sweet, Yumi Izumisato, Lawrence W. Way, Orlo H. Clark, Umesh Masharani, and Quan-Yang Duh
Arch Surg. 2007;142(12):1202-1204.
ABSTRACT | FULL TEXT